| 34.17 Data as of 2:25pm ET |  +0.55 / +1.65%Today’s Change | 25.01 Today|||52-Week Range 38.32 | +30.29% Year-to-Date |
| Merck Enters into Strategic Deal - Analyst Blog May 22 / Zacks.com | Setback for Endo Health on Opana ER - Analyst Blog May 13 / Zacks.com |
| Endo Health Solutions Inc Stock Hold Recommendation Reiterated (ENDP) May 16 / TheStreet.com |
| Previous close | 33.62 |
| Today’s open | 33.73 |
| Day’s range | 33.39 - 34.22 |
| Volume | 574,717 |
| Average volume (3 months) | 2,630,471 |
| Market cap | $3.8B |
| Dividend yield | -- |
| Earnings growth (last year) | -512.90% |
| Earnings growth (this year) | -15.26% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +10.89% |
| P/E ratio | NM |
| Price/Sales | 1.00 |
| Price/Book | 3.47 |
| Today’s change | Today’s % change | |
|---|---|---|
| SLXPSalix Pharmaceutical... | -0.10 | -0.17% |
| MDVNMedivation Inc | +1.33 | +2.74% |
| JAZZJazz Pharmaceuticals... | +1.23 | +2.00% |
| THRXTheravance Inc | +0.21 | +0.58% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $1.16 |
| Annual revenue (last year) | $3.0B |
| Annual profit (last year) | -$740.3M |
| Net profit margin | -24.45% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Rajiv de Silva, MBA |
Chief Operating Officer Julie H. McHugh, MBA |
Corporate headquarters Malvern, Pennsylvania |
.
